Wilbanks Smith & Thomas Asset Management LLC lowered its stake in Markel Corporation (NYSE:MKL) by 0.8% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 234 shares of the insurance provider’s stock after selling 2 shares during the period. Wilbanks Smith & Thomas Asset Management LLC’s holdings in Markel Corporation were worth $228,000 at the end of the most recent quarter.
Other institutional investors also recently modified their holdings of the company. Proficio Capital Partners LLC increased its holdings in shares of Markel Corporation by 40.3% in the second quarter. Proficio Capital Partners LLC now owns 94 shares of the insurance provider’s stock valued at $101,000 after purchasing an additional 27 shares in the last quarter. Korea Investment CORP increased its holdings in shares of Markel Corporation by 138.9% in the second quarter. Korea Investment CORP now owns 129 shares of the insurance provider’s stock valued at $126,000 after purchasing an additional 75 shares in the last quarter. BDO Wealth Advisors LLC acquired a new stake in shares of Markel Corporation in the second quarter valued at approximately $166,000. Quantbot Technologies LP increased its holdings in shares of Markel Corporation by 775.0% in the second quarter. Quantbot Technologies LP now owns 210 shares of the insurance provider’s stock valued at $204,000 after purchasing an additional 186 shares in the last quarter. Finally, Allen Investment Management LLC acquired a new stake in shares of Markel Corporation in the second quarter valued at approximately $215,000. 76.47% of the stock is owned by institutional investors and hedge funds.
Shares of Markel Corporation (MKL) traded up 0.78% during mid-day trading on Friday, hitting $1078.17. 2,761 shares of the company were exchanged. Markel Corporation has a 12-month low of $811.05 and a 12-month high of $1,105.23. The firm has a market capitalization of $15.00 billion, a P/E ratio of 37.28 and a beta of 1.03. The company’s 50-day moving average price is $1,053.62 and its 200-day moving average price is $1,005.97.
Markel Corporation (NYSE:MKL) last issued its quarterly earnings data on Wednesday, July 26th. The insurance provider reported $9.94 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $6.27 by $3.67. The business had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.46 billion. Markel Corporation had a net margin of 7.58% and a return on equity of 4.81%. Equities research analysts predict that Markel Corporation will post $27.56 earnings per share for the current fiscal year.
TRADEMARK VIOLATION WARNING: “Wilbanks Smith & Thomas Asset Management LLC Lowers Position in Markel Corporation (MKL)” was originally reported by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this story on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://sportsperspectives.com/2017/10/13/wilbanks-smith-thomas-asset-management-llc-lowers-position-in-markel-corporation-mkl.html.
MKL has been the subject of a number of research reports. ValuEngine raised shares of Markel Corporation from a “sell” rating to a “hold” rating in a report on Tuesday, August 1st. Zacks Investment Research lowered shares of Markel Corporation from a “buy” rating to a “hold” rating in a report on Tuesday, October 3rd. BidaskClub raised shares of Markel Corporation from a “sell” rating to a “hold” rating in a report on Wednesday, July 5th. Boenning Scattergood set a $1,050.00 price target on shares of Markel Corporation and gave the company a “buy” rating in a report on Wednesday, July 26th. Finally, Royal Bank Of Canada reissued a “hold” rating and issued a $1,050.00 price target on shares of Markel Corporation in a report on Tuesday, October 3rd. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Markel Corporation has an average rating of “Hold” and an average target price of $1,050.00.
In other news, EVP Bradley James Kiscaden sold 350 shares of the firm’s stock in a transaction on Wednesday, August 2nd. The shares were sold at an average price of $1,074.56, for a total transaction of $376,096.00. Following the completion of the transaction, the executive vice president now owns 6,817 shares of the company’s stock, valued at $7,325,275.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Alan I. Kirshner sold 100 shares of the firm’s stock in a transaction on Tuesday, October 3rd. The shares were sold at an average price of $1,077.70, for a total transaction of $107,770.00. The disclosure for this sale can be found here. Insiders have sold 6,027 shares of company stock valued at $6,438,990 in the last ninety days. Insiders own 2.53% of the company’s stock.
About Markel Corporation
Markel Corporation is a financial holding company serving a range of markets. The Company’s principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace.
Receive News & Ratings for Markel Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel Corporation and related companies with MarketBeat.com's FREE daily email newsletter.